You just read:

Genomic Health and Epic Sciences Announce Strategic Collaboration to Deliver Novel AR-V7 Liquid Biopsy Test to Predict Treatment Response in Metastatic Prostate Cancer

News provided by

Genomic Health, Inc.

Jul 07, 2016, 00:05 ET